DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Goldner T, Hewlett G, Ettischer N, Ruebsamen-Schaeff H, Zimmermann H, Lischka P.
The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.
J Virol 2011;
85 (20) 10884-10893
We do not assume any responsibility for the contents of the web pages of other providers.